We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

131 hedge funds and large institutions have $84.1M invested in ImmunityBio in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 11

12% more funds holding

Funds holding: 117 → 131 (+14)

10% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 30

4% less call options, than puts

Call options by funds: $4.51M | Put options by funds: $4.7M

1.5% less ownership

Funds ownership: 8.97% → 7.47% (-1.5%)

23% less capital invested

Capital invested by funds: $109M → $84.1M (-$24.6M)

Holders
131
Holders Change
+14
Holders Change %
+11.97%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
33
Reduced
30
Closed
11
Calls
$4.51M
Puts
$4.7M
Net Calls
-$190K
Net Calls Change
-$2.05M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$8.72M
2
AC
Armistice Capital
New York
+$6.98M
3
BlackRock
BlackRock
New York
+$2.64M
4
CS
Credit Suisse
Switzerland
+$1.04M
5
Group One Trading
Group One Trading
Illinois
+$897K

Top Sellers

1
DFCM
Dark Forest Capital Management
Puerto Rico
-$566K
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$537K
3
Jane Street
Jane Street
New York
-$295K
4
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$193K
5
State Street
State Street
Massachusetts
-$116K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
26
UBS AM
Illinois
$309K – – –
DekaBank Deutsche Girozentrale
27
DekaBank Deutsche Girozentrale
Germany
$309K – – –
Corient Private Wealth
28
Corient Private Wealth
Florida
$294K +$229K +114,272 +192%
William Blair & Company
29
William Blair & Company
Illinois
$275K +$218K +108,431 +201%
JAFL
30
Jay A. Fishman Ltd
Michigan
$274K – – –
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$240K -$10.7K -5,350 -4%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$238K -$22K -10,966 -7%
SC
33
Sculptor Capital
New York
$222K – – –
Legal & General Group
34
Legal & General Group
United Kingdom
$199K -$2.82K -1,403 -1%
T. Rowe Price Associates
35
T. Rowe Price Associates
Maryland
$187K -$64.3K -32,028 -22%
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
$164K -$2.67K -1,330 -1%
MIC
37
Meridian Investment Counsel
California
$163K – – –
SFFS
38
Stonehage Fleming Financial Services
Jersey
$144K +$171K +85,000 New
Verition Fund Management
39
Verition Fund Management
Connecticut
$143K +$170K +84,770 New
WPA
40
Winning Points Advisors
Florida
$143K -$6.81K -3,390 -4%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$143K +$69.3K +34,531 +69%
Principal Financial Group
42
Principal Financial Group
Iowa
$129K +$4.35K +2,166 +3%
RG
43
Rathbones Group
United Kingdom
$124K +$147K +73,420 New
Janus Henderson Group
44
Janus Henderson Group
United Kingdom
$101K +$68 +34 +0.1%
MIM
45
MetLife Investment Management
New Jersey
$98.8K – – –
ETC
46
Exchange Traded Concepts
Oklahoma
$98.3K +$21.3K +10,596 +22%
AIG
47
American International Group
New York
$96.1K +$7.62K +3,795 +7%
Deutsche Bank
48
Deutsche Bank
Germany
$90.8K – – –
WE
49
Wealth Effects
Massachusetts
$90.4K -$35.1K -17,500 -25%
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$87K +$97.1K +48,360 New
1
2
3 4 5

IBRX Hedge Fund Activity: Q3 2023 in Review

131 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q3 2023, worth a combined $84.1M — down 23% from $109M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IBRX positions and 11 closed out — a net gain of 18 holders — while 33 added to existing stakes and 30 trimmed.

The largest buyer was Vanguard Group, adding an estimated $8.72M. The largest seller was Dark Forest Capital Management, exiting entirely with an estimated $566K sold.

  • 131 institutional investors held ImmunityBio (IBRX) as of Q3 2023, up from 117 in Q2 2023.
  • Funds reported $84.1M of ImmunityBio stock for Q3 2023, down 23% quarter-over-quarter.
  • 29 funds opened new ImmunityBio positions in Q3 2023 and 11 closed out, a net change of +18 holders.
  • The largest ImmunityBio buyer in Q3 2023 was Vanguard Group, an estimated $8.72M added.
  • The largest ImmunityBio seller in Q3 2023 was Dark Forest Capital Management, an estimated $566K sold.

Based on aggregated 13F filings for Q3 2023.